Tumor extrachromosomal DNA: Biogenesis and recent advances in the field
Extrachromosomal DNA (ecDNA) is a self-replicating circular DNA originating from the chromosomal genome and exists outside the chromosome. It contains specific gene sequences and non-coding regions that regulate transcription. Recent studies have demonstrated that ecDNA is present in various maligna...
Gespeichert in:
Veröffentlicht in: | Biomedicine & pharmacotherapy 2024-05, Vol.174, p.116588-116588, Article 116588 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 116588 |
---|---|
container_issue | |
container_start_page | 116588 |
container_title | Biomedicine & pharmacotherapy |
container_volume | 174 |
creator | Wu, Haomin Liu, Shiqi Wu, Di Zhou, Haonan Wu, Gang |
description | Extrachromosomal DNA (ecDNA) is a self-replicating circular DNA originating from the chromosomal genome and exists outside the chromosome. It contains specific gene sequences and non-coding regions that regulate transcription. Recent studies have demonstrated that ecDNA is present in various malignant tumors. Malignant tumor development and poor prognosis may depend on ecDNA's distinctive ring structure, which assists in amplifying oncogenes. During cell division, an uneven distribution of ecDNA significantly enhances tumor cells' heterogeneity, allowing tumor cells to adapt to changes in the tumor microenvironment and making them more resistant to treatments. The application of ecDNA as a cancer biomarker and therapeutic target holds great potential. This article examines the latest advancements in this area and discusses the potential clinical applications of ecDNA.
[Display omitted]
•Proposed and explained all the possible models for ecDNA biogenesis.•Described the signaling pathways that involved in the regulation of ecDNA biogenesis.•Described the mechanism of ecDNA supporting tumor progression.•The prospect of ecDNA application for cancer therapy was explained. |
doi_str_mv | 10.1016/j.biopha.2024.116588 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3038444420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332224004724</els_id><sourcerecordid>3038444420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-98dbcd0e2c85e2c0603800ca46ac290d498fe2fd1ce64feb4b09f21e993887e53</originalsourceid><addsrcrecordid>eNp9kEtP3DAQxy0EKgvtN0DIRy5ZxnYeNgckoOUhoXKhZ8uxJ6xXSbzYWUS_PUYBjsxh5vJ_aH6EHDFYMmD16XrZ-rBZmSUHXi4Zqyspd8iCqQqKGqDZJQtoKlEIwfk-OUhpDQBVLeQPsi9kzYRSzYLcPG6HECm-TtHYVQxDSGEwPf399-KMXvrwhCMmn6gZHY1ocZyocS9mtJioH-m0Qtp57N1PsteZPuGvj3tI_l3_eby6Le4fbu6uLu4LK6pmKpR0rXWA3MoqL6hBSABrytpYrsCVSnbIO8cs1mWHbdmC6jhDpYSUDVbikJzMuZsYnreYJj34ZLHvzYhhm7TIgWUeDllazlIbQ0oRO72JfjDxv2ag3xHqtZ4R6neEekaYbccfDdt2QPdl-mSWBeezAPOfLx6jTtZjJuJ8JjRpF_z3DW-L_oOC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3038444420</pqid></control><display><type>article</type><title>Tumor extrachromosomal DNA: Biogenesis and recent advances in the field</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Wu, Haomin ; Liu, Shiqi ; Wu, Di ; Zhou, Haonan ; Wu, Gang</creator><creatorcontrib>Wu, Haomin ; Liu, Shiqi ; Wu, Di ; Zhou, Haonan ; Wu, Gang</creatorcontrib><description>Extrachromosomal DNA (ecDNA) is a self-replicating circular DNA originating from the chromosomal genome and exists outside the chromosome. It contains specific gene sequences and non-coding regions that regulate transcription. Recent studies have demonstrated that ecDNA is present in various malignant tumors. Malignant tumor development and poor prognosis may depend on ecDNA's distinctive ring structure, which assists in amplifying oncogenes. During cell division, an uneven distribution of ecDNA significantly enhances tumor cells' heterogeneity, allowing tumor cells to adapt to changes in the tumor microenvironment and making them more resistant to treatments. The application of ecDNA as a cancer biomarker and therapeutic target holds great potential. This article examines the latest advancements in this area and discusses the potential clinical applications of ecDNA.
[Display omitted]
•Proposed and explained all the possible models for ecDNA biogenesis.•Described the signaling pathways that involved in the regulation of ecDNA biogenesis.•Described the mechanism of ecDNA supporting tumor progression.•The prospect of ecDNA application for cancer therapy was explained.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2024.116588</identifier><identifier>PMID: 38613997</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Biomarkers, Tumor - genetics ; DNA, Circular - genetics ; DNA, Neoplasm - genetics ; ecDNA,tumor heterogeneity,drug resistance,biomarkers,genetics ; Humans ; Neoplasms - genetics ; Tumor Microenvironment - genetics</subject><ispartof>Biomedicine & pharmacotherapy, 2024-05, Vol.174, p.116588-116588, Article 116588</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c357t-98dbcd0e2c85e2c0603800ca46ac290d498fe2fd1ce64feb4b09f21e993887e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biopha.2024.116588$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38613997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Haomin</creatorcontrib><creatorcontrib>Liu, Shiqi</creatorcontrib><creatorcontrib>Wu, Di</creatorcontrib><creatorcontrib>Zhou, Haonan</creatorcontrib><creatorcontrib>Wu, Gang</creatorcontrib><title>Tumor extrachromosomal DNA: Biogenesis and recent advances in the field</title><title>Biomedicine & pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>Extrachromosomal DNA (ecDNA) is a self-replicating circular DNA originating from the chromosomal genome and exists outside the chromosome. It contains specific gene sequences and non-coding regions that regulate transcription. Recent studies have demonstrated that ecDNA is present in various malignant tumors. Malignant tumor development and poor prognosis may depend on ecDNA's distinctive ring structure, which assists in amplifying oncogenes. During cell division, an uneven distribution of ecDNA significantly enhances tumor cells' heterogeneity, allowing tumor cells to adapt to changes in the tumor microenvironment and making them more resistant to treatments. The application of ecDNA as a cancer biomarker and therapeutic target holds great potential. This article examines the latest advancements in this area and discusses the potential clinical applications of ecDNA.
[Display omitted]
•Proposed and explained all the possible models for ecDNA biogenesis.•Described the signaling pathways that involved in the regulation of ecDNA biogenesis.•Described the mechanism of ecDNA supporting tumor progression.•The prospect of ecDNA application for cancer therapy was explained.</description><subject>Animals</subject><subject>Biomarkers, Tumor - genetics</subject><subject>DNA, Circular - genetics</subject><subject>DNA, Neoplasm - genetics</subject><subject>ecDNA,tumor heterogeneity,drug resistance,biomarkers,genetics</subject><subject>Humans</subject><subject>Neoplasms - genetics</subject><subject>Tumor Microenvironment - genetics</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtP3DAQxy0EKgvtN0DIRy5ZxnYeNgckoOUhoXKhZ8uxJ6xXSbzYWUS_PUYBjsxh5vJ_aH6EHDFYMmD16XrZ-rBZmSUHXi4Zqyspd8iCqQqKGqDZJQtoKlEIwfk-OUhpDQBVLeQPsi9kzYRSzYLcPG6HECm-TtHYVQxDSGEwPf399-KMXvrwhCMmn6gZHY1ocZyocS9mtJioH-m0Qtp57N1PsteZPuGvj3tI_l3_eby6Le4fbu6uLu4LK6pmKpR0rXWA3MoqL6hBSABrytpYrsCVSnbIO8cs1mWHbdmC6jhDpYSUDVbikJzMuZsYnreYJj34ZLHvzYhhm7TIgWUeDllazlIbQ0oRO72JfjDxv2ag3xHqtZ4R6neEekaYbccfDdt2QPdl-mSWBeezAPOfLx6jTtZjJuJ8JjRpF_z3DW-L_oOC</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Wu, Haomin</creator><creator>Liu, Shiqi</creator><creator>Wu, Di</creator><creator>Zhou, Haonan</creator><creator>Wu, Gang</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202405</creationdate><title>Tumor extrachromosomal DNA: Biogenesis and recent advances in the field</title><author>Wu, Haomin ; Liu, Shiqi ; Wu, Di ; Zhou, Haonan ; Wu, Gang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-98dbcd0e2c85e2c0603800ca46ac290d498fe2fd1ce64feb4b09f21e993887e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Biomarkers, Tumor - genetics</topic><topic>DNA, Circular - genetics</topic><topic>DNA, Neoplasm - genetics</topic><topic>ecDNA,tumor heterogeneity,drug resistance,biomarkers,genetics</topic><topic>Humans</topic><topic>Neoplasms - genetics</topic><topic>Tumor Microenvironment - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Haomin</creatorcontrib><creatorcontrib>Liu, Shiqi</creatorcontrib><creatorcontrib>Wu, Di</creatorcontrib><creatorcontrib>Zhou, Haonan</creatorcontrib><creatorcontrib>Wu, Gang</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine & pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Haomin</au><au>Liu, Shiqi</au><au>Wu, Di</au><au>Zhou, Haonan</au><au>Wu, Gang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor extrachromosomal DNA: Biogenesis and recent advances in the field</atitle><jtitle>Biomedicine & pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2024-05</date><risdate>2024</risdate><volume>174</volume><spage>116588</spage><epage>116588</epage><pages>116588-116588</pages><artnum>116588</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Extrachromosomal DNA (ecDNA) is a self-replicating circular DNA originating from the chromosomal genome and exists outside the chromosome. It contains specific gene sequences and non-coding regions that regulate transcription. Recent studies have demonstrated that ecDNA is present in various malignant tumors. Malignant tumor development and poor prognosis may depend on ecDNA's distinctive ring structure, which assists in amplifying oncogenes. During cell division, an uneven distribution of ecDNA significantly enhances tumor cells' heterogeneity, allowing tumor cells to adapt to changes in the tumor microenvironment and making them more resistant to treatments. The application of ecDNA as a cancer biomarker and therapeutic target holds great potential. This article examines the latest advancements in this area and discusses the potential clinical applications of ecDNA.
[Display omitted]
•Proposed and explained all the possible models for ecDNA biogenesis.•Described the signaling pathways that involved in the regulation of ecDNA biogenesis.•Described the mechanism of ecDNA supporting tumor progression.•The prospect of ecDNA application for cancer therapy was explained.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>38613997</pmid><doi>10.1016/j.biopha.2024.116588</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0753-3322 |
ispartof | Biomedicine & pharmacotherapy, 2024-05, Vol.174, p.116588-116588, Article 116588 |
issn | 0753-3322 1950-6007 |
language | eng |
recordid | cdi_proquest_miscellaneous_3038444420 |
source | MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
subjects | Animals Biomarkers, Tumor - genetics DNA, Circular - genetics DNA, Neoplasm - genetics ecDNA,tumor heterogeneity,drug resistance,biomarkers,genetics Humans Neoplasms - genetics Tumor Microenvironment - genetics |
title | Tumor extrachromosomal DNA: Biogenesis and recent advances in the field |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T18%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20extrachromosomal%20DNA:%20Biogenesis%20and%20recent%20advances%20in%20the%20field&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Wu,%20Haomin&rft.date=2024-05&rft.volume=174&rft.spage=116588&rft.epage=116588&rft.pages=116588-116588&rft.artnum=116588&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2024.116588&rft_dat=%3Cproquest_cross%3E3038444420%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3038444420&rft_id=info:pmid/38613997&rft_els_id=S0753332224004724&rfr_iscdi=true |